The following article speculates that the $1 billion worth on antivirals will be equally split between Tamiflu and Relenza....
If this is true we are looking at approx US$50 million for Biota.
jojo
Gilead developed the anti-viral drug Tamiflu, which was singled out for mention in Bush's announcement, along with Relenza, made by GlaxoSmithKline of England. Under a licensing deal, Tamiflu is manufactured by Roche while Gilead receives royalties, typically 10 percent. Assuming the $1.029 billion Bush has allocated for anti-viral drugs is split evenly among Tamiflu and Relenza, Gilead's share would likely be about $50 million.